allogeneic mesenchymal stem cells

Cell therapyexperimental

MSC may refer to: — Wikipedia

Clinical trial activity

46 trials · 67 clinical orgs · 0 marketing orgs

Phase 1
29
Phase 2
28
Phase 3
4
Phase 4
0

Earliest trial started Jan 1, 2009 (NCT00827398)

Timeline

2000s

  1. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2010

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetTissue restoration

    tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • msc
  • msc
  • plasma reach protein

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07240987Phase 1/Phase 2 (Phase 2)Nov 15, 2025People's Liberation Army of China
NCT06886646Phase 2Sep 15, 2025Assistance Publique - Hôpitaux de Paris
NCT06911281Phase 1Jun 30, 2025Huazhong University of Science and Technology
NCT06781333Phase 2Mar 1, 2025University of Miami
NCT06738576Phase 1Dec 11, 2024Universidad Autonoma de Madrid
NCT06464588Phase 1Oct 31, 2024Emory University, The Marcus Foundation
NCT06231771Phase 1/Phase 2 (Phase 2)May 31, 2024Supergenics Life Science Sdn. Bhd.
NCT06012604Phase 1Sep 30, 2023Blood Transfusion Centre of Slovenia, University of Ljubljana
NCT05728346N/ASep 1, 2023Guangzhou Medical University
NCT05333029Phase 2Apr 30, 2023Case Western Reserve University
NCT05520125Phase 1/Phase 2 (Phase 2)Nov 1, 2022Belarusian Medical Academy of Post-Graduate Education, Government of Belarus, National Academy of Sciences of Belarus
NCT05520112Phase 1/Phase 2 (Phase 2)Nov 1, 2022Belarusian Medical Academy of Post-Graduate Education, Government of Belarus, National Academy of Sciences of Belarus
NCT05934825Phase 1/Phase 2 (Phase 2)Oct 26, 2022Andalusian Network for Design and Translation of Advanced Therapies
NCT05286255Phase 1May 4, 2022Medical University of South Carolina
NCT05233774Phase 2Dec 28, 2021bioRASI, LLC, Longeveron LLC
NCT04776239Phase 1/Phase 2 (Phase 2)Aug 16, 2021National Heart, Lung, and Blood Institute (NHLBI), University of Miami
NCT06103409Phase 1/Phase 2 (Phase 2)Jun 30, 2021Hospital Central Dr. Plácido D. Rodriguez Rivero, San Felipe, Yaracuy, Instituto Venezolano de Investigaciones Cientificas
NCT05086939Phase 3May 26, 2021Institut d'Investigacions Biomèdiques August Pi i Sunyer, Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL), Spanish Clinical Research Network, University of Barcelona, University of Salamanca
NCT04780685Phase 2Mar 20, 2021bioRASI, LLC, Providence Saint John's Health Center, Stemedica
NCT04626583Phase 1Jan 15, 2021Department of Defense, University of Illinois at Chicago
Showing 20 of 46 trials
Page 1 / 3

Organizations

Research & Development (67)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Instituto Venezolano de Investigaciones CientificasAcademic/Hospital3312018
University of IndonesiaAcademic/Hospital3322014
Belarusian Medical Academy of Post-Graduate EducationAcademic/Hospital2012022
bioRASI, LLCFor profit2012021
Government of BelarusGovernment2012022
Hospital Central Dr. Plácido D. Rodriguez Rivero, San Felipe, YaracuyAcademic/Hospital2012018
Mayo ClinicAcademic/Hospital2212017
National Academy of Sciences of BelarusAcademic/Hospital2212022
National Heart, Lung, and Blood Institute (NHLBI)Government2112015
Royan InstituteAcademic/Hospital2222009
Universidad Autonoma de MadridAcademic/Hospital2222020
University of MiamiAcademic/Hospital2212021
Andalusian Network for Design and Translation of Advanced TherapiesAcademic/Hospital1112022
Anterogen Co., Ltd.For profit1112015
Assistance Publique - Hôpitaux de ParisAcademic/Hospital1112025
Bakirkoy Dr. Sadi Konuk Research and Training HospitalAcademic/Hospital1112020
Blood Transfusion Centre of SloveniaAcademic/Hospital1012023
Cairo UniversityAcademic/Hospital1012014
Capital Medical UniversityAcademic/Hospital1012020
Case Western Reserve UniversityAcademic/Hospital1112023
67 organizations
Page 1 / 4